ID

19703

Descripción

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00415285

Link

https://clinicaltrials.gov/show/NCT00415285

Palabras clave

  1. 23/1/17 23/1/17 -
Subido en

23 de enero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Neoplasms NCT00415285

Eligibility Breast Neoplasms NCT00415285

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed breast carcinoma.
Descripción

Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
early stage breast cancer (stage 1, 2, 3).
Descripción

Early-Stage Breast Carcinoma TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2986665
UMLS CUI [1,2]
C3258246
no evidence of disease outside the breast or chest wall, except ipsilateral axillary lymph nodes.
Descripción

Disease outside Breast | Disease outside chest wall | Axillary lymph nodes Ipsilateral

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205101
UMLS CUI [1,3]
C0006141
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205101
UMLS CUI [2,3]
C1279035
UMLS CUI [3,1]
C0729594
UMLS CUI [3,2]
C0441989
18 years of age or older.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
Descripción

Eligibility Determination Final Health Professionals

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013893
UMLS CUI [1,2]
C3853528
UMLS CUI [1,3]
C1704312
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy, hormonal therapy, biologic therapy or radiation therapy for breast cancer.
Descripción

Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma | Biological treatment Breast Carcinoma | Therapeutic radiology procedure Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0678222
UMLS CUI [3,1]
C1531518
UMLS CUI [3,2]
C0678222
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0678222
major surgery within 28 days of study entry.
Descripción

major surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0679637
evidence of cns metastases.
Descripción

CNS metastases Evidence of

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0332120
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
Descripción

Eligibility Determination Final Health Professionals

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013893
UMLS CUI [1,2]
C3853528
UMLS CUI [1,3]
C1704312

Similar models

Eligibility Breast Neoplasms NCT00415285

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma
Item
histologically or cytologically confirmed breast carcinoma.
boolean
C0678222 (UMLS CUI [1])
Early-Stage Breast Carcinoma TNM clinical staging
Item
early stage breast cancer (stage 1, 2, 3).
boolean
C2986665 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Disease outside Breast | Disease outside chest wall | Axillary lymph nodes Ipsilateral
Item
no evidence of disease outside the breast or chest wall, except ipsilateral axillary lymph nodes.
boolean
C0012634 (UMLS CUI [1,1])
C0205101 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0205101 (UMLS CUI [2,2])
C1279035 (UMLS CUI [2,3])
C0729594 (UMLS CUI [3,1])
C0441989 (UMLS CUI [3,2])
Age
Item
18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Eligibility Determination Final Health Professionals
Item
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
boolean
C0013893 (UMLS CUI [1,1])
C3853528 (UMLS CUI [1,2])
C1704312 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma | Biological treatment Breast Carcinoma | Therapeutic radiology procedure Breast Carcinoma
Item
prior chemotherapy, hormonal therapy, biologic therapy or radiation therapy for breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1531518 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
major surgery
Item
major surgery within 28 days of study entry.
boolean
C0679637 (UMLS CUI [1])
CNS metastases Evidence of
Item
evidence of cns metastases.
boolean
C0686377 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Eligibility Determination Final Health Professionals
Item
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
boolean
C0013893 (UMLS CUI [1,1])
C3853528 (UMLS CUI [1,2])
C1704312 (UMLS CUI [1,3])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial